This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roggero, R.
Right arrow Articles by Ben Mamoun, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roggero, R.
Right arrow Articles by Ben Mamoun, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2004, p. 2816-2824, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.2816-2824.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Unraveling the Mode of Action of the Antimalarial Choline Analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae

Rodolphe Roggero,1,2 Rachel Zufferey,2,3,4 Mihaela Minca,2,3 Eric Richier,1 Michele Calas,1 Henri Vial,1 and Choukri Ben Mamoun2,3*

Center for Microbial Pathogenesis,2 Department of Genetics and Development Biology,3 Department of Pathology, University of Connecticut Health Center, Farmington, Connecticut 06030,4 Dynamique Moleculaire des Interactions Membranaires, CNRS UMR 5539, Universite Montpellier II, 34095 Montpellier Cedex 05, France1

Received 18 February 2004/ Returned for modification 1 April 2004/ Accepted 16 April 2004

Pharmacological studies have indicated that the choline analog G25 is a potent inhibitor of Plasmodium falciparum growth in vitro and in vivo. Although choline transport has been suggested to be the target of G25, the exact mode of action of this compound is not known. Here we show that, similar to its effects on P. falciparum, G25 prevents choline entry into Saccharomyces cerevisiae cells and inhibits S. cerevisiae growth. However, we show that the uptake of this compound is not mediated by the choline carrier Hnm1. An hnm1{Delta} yeast mutant, which lacks the only choline transporter gene HNM1, was not altered in the transport of a labeled analog of this compound. Eleven yeast mutants lacking genes involved in different steps of phospholipid biosynthesis were analyzed for their sensitivity to G25. Four mutants affected in the de novo cytidyldiphosphate-choline-dependent phosphatidylcholine biosynthetic pathway and, surprisingly, a mutant strain lacking the phosphatidylserine decarboxylase-encoding gene PSD1 (but not PSD2) were found to be highly resistant to this compound. Based on these data for S. cerevisiae, labeling studies in P. falciparum were performed to examine the effect of G25 on the biosynthetic pathways of the major phospholipids phosphatidylcholine and phosphatidylethanolamine. Labeling studies in P. falciparum and in vitro studies with recombinant P. falciparum phosphatidylserine decarboxylase further supported the inhibition of both the de novo phosphatidylcholine metabolic pathway and the synthesis of phosphatidylethanolamine from phosphatidylserine. Together, our data indicate that G25 specifically targets the pathways for synthesis of the two major phospholipids, phosphatidylcholine and phosphatidylethanolamine, to exert its antimalarial activity.

* Corresponding author. Mailing address: Center for Microbial Pathogenesis, Department of Genetics and Development Biology, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030. Phone: (860) 679-3544. Fax: (860) 679-8130. E-mail: choukri{at}up.uchc.edu.

Antimicrobial Agents and Chemotherapy, August 2004, p. 2816-2824, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.2816-2824.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Choubey, V., Maity, P., Guha, M., Kumar, S., Srivastava, K., Puri, S. K., Bandyopadhyay, U. (2007). Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism. Antimicrob. Agents Chemother. 51: 696-706 [Abstract] [Full Text]  
  • Witola, W. H., Pessi, G., El Bissati, K., Reynolds, J. M., Mamoun, C. B. (2006). Localization of the Phosphoethanolamine Methyltransferase of the Human Malaria Parasite Plasmodium falciparum to the Golgi Apparatus. J. Biol. Chem. 281: 21305-21311 [Abstract] [Full Text]  
  • Pessi, G., Choi, J.-Y., Reynolds, J. M., Voelker, D. R., Mamoun, C. B. (2005). In Vivo Evidence for the Specificity of Plasmodium falciparum Phosphoethanolamine Methyltransferase and Its Coupling to the Kennedy Pathway. J. Biol. Chem. 280: 12461-12466 [Abstract] [Full Text]  
  • Biagini, G. A., Pasini, E. M., Hughes, R., De Koning, H. P., Vial, H. J., O'Neill, P. M., Ward, S. A., Bray, P. G. (2004). Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 104: 3372-3377 [Abstract] [Full Text]  
  • Vial, H. J., Wein, S., Farenc, C., Kocken, C., Nicolas, O., Ancelin, M. L., Bressolle, F., Thomas, A., Calas, M. (2004). Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. USA 101: 15458-15463 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»